Quality Improvement/Patient Safety II-QI in Outpatient Settings: Improving Screening and Preventive Care
Improving Antibiotic Durations for Skin and Soft Tissue Infections in Pediatric Urgent Care Clinics
Sunday, April 24, 2022
8:00 AM – 8:15 AM US MT
Location: Convention Center: Four Seasons Ballroom 2-3
CE: Enduring CME: 0.25
Publication Number: 2180.1
Megan Hamner, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Amanda Nedved, Children's Mercy, Lenexa, KS, United States; Holly Austin, Children's Mercy Hospitals and Clinics, Leawood, KS, United States; Donna Wyly, Children's Mercy Hospital, Independence, MO, United States; ALAINA BURNS, CHILDREN'S MERCY KANSAS CITY, KANSAS CITY, MO, United States; Brian R. Lee, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Rana E. El Feghaly, Children’s Mercy Kansas City, UMKC, Kansas City, MO, United States
Presenting Author(s)
Megan J. Hamner, MD
Pediatric Infectious Diseases Fellow Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States
Participants should be aware of the following financial/non-financial relationships:
Megan J. Hamner, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Amanda Nedved, Nedved, M.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Holly Austin, BA, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Donna Wyly, Wyly, MSN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
ALAINA BURNS, BURNS, PharmD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Brian R. Lee, PhD, MPH: ● Merck (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Pfizer (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Rana E. El Feghaly, MD, MSCI: I do not have any relevant financial / non-financial relationships with any proprietary interests.
